Home  >> Transactions>> Repligen acquires Atoll GmbH

Repligen acquires Atoll GmbH

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has acquired Atoll GmBH (“Atoll”) of Weingarten, Germany, an innovator and manufacturer of MediaScout® pre-packed chromatography columns used in process development and clinical manufacturing of biologic drugs. The acquisition of Atoll expands Repligen’s pre-packed column chromatography portfolio into high throughput process development screening, complementing the Company’s existing strength in clinical production-scale columns. The combined offering will provide bioprocessing customers with breadth and flexibility in choosing column size, chromatography media and packed bed formats.

Repligen purchased Atoll from UV-Cap GmbH & Co. KG on April 1, 2016 for a combination of $9.1 million in cash and 538,700 shares of Repligen common stock, for total upfront consideration of approximately $22.5 million. The agreement also includes a potential payment of €1.0 million, contingent on achieving a predetermined revenue target for the year 2016. The Company expects sales of Atoll products to add approximately $3.0-$3.5 million in revenue for the remaining nine months of 2016.

EC M&A acted as the exclusive financial advisor to Repligen on this transaction.

Others

Entegris Has Acquired Flex Concepts, Inc.      Learn More >>
Hänsel Group has sold a majority stake to Possehl      Learn More >>
Entegris has acquired SAES Pure Gas Business from SAES Group      Learn More >>
Ldetek has been sold to Battery Ventures’ Process Sensing Technologies Group      Learn More >>
Axel Johnson International acquires MAK Aandrijvingen      Learn More >>
SPX has acquired CUES, Inc.      Learn More >>
Dickson Data has been sold to May River Capital      Learn More >>
SPX has acquired Schonstedt Instrument Company      Learn More >>
Quantachrome Instruments has been sold to Anton Paar      Learn More >>
PIP Global has partnered with Audax Private Equity      Learn More >>
Harvard Bioscience has acquired Data Sciences International      Learn More >>
Horizon Technology has been sold to Biotage      Learn More >>